Skip to main content

What the FDA labels say about taking them together

Ranolazine and sirolimus

Ranolazine's FDA label of January 23, 2026 names sirolimus in its drug interactions section; the sirolimus labels PlainMeds reads (4) do not name ranolazine. The ranolazine label: “Doses of other sensitive CYP3A substrates (e.g., lovastatin) and CYP3A substrates with narrow therapeutic range may need to be reduced with ranolazine.”

Check it at the source: the ranolazine FDA label on DailyMed (effective January 23, 2026, Glenmark Pharmaceuticals Inc., USA); the sirolimus FDA label on DailyMed (effective January 28, 2026, Glenmark Pharmaceuticals Inc., USA).

What does the ranolazine label say about sirolimus?

Ranolazine label, drug interactions

Doses of other sensitive CYP3A substrates (e.g., lovastatin) and CYP3A substrates with narrow therapeutic range (e.g., cyclosporine, tacrolimus, sirolimus) may need to be reduced with ranolazine.

Source: FDA drug label (Aspruzyo Sprinkle, NDA216018), SUN PHARMACEUTICAL INDUSTRIES, INC., effective January 29, 2025 (SPL set dd9f81e4-50da-4551-aed5-559d304df42e), via openFDA

Source: FDA drug label (Ranolazine), Glenmark Pharmaceuticals Inc., USA, effective January 23, 2026 (SPL set 0cf58732-c242-49b0-8e3f-248778b4458d), via openFDA; the full label on DailyMed

What does the sirolimus label say about ranolazine?

Sirolimus's label (effective January 28, 2026) and its 3 other brand-application labels do not name ranolazine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (sirolimus), Glenmark Pharmaceuticals Inc., USA, effective January 28, 2026 (SPL set 57fb4d90-3ccb-4a69-af1e-53be83f7a504), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

28Ranolazine generic labelers
17Sirolimus generic labelers
RanolazineSirolimus
Labeled forAnginaOrgan transplant rejection
Boxed warningNoYes
Pharmacy cost (NADAC)$0.165 per tablet 500 mg tablet$0.723 per tablet 1 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?